A - Human Necessities – 61 – M
Patent
A - Human Necessities
61
M
A61M 1/16 (2006.01)
Patent
CA 2676951
The present invention relates to high cut-off hemodialysis membranes for the treatment of chronic hemodialysis (CHD) patients, with the potential to improve long-term survival of these patients by reducing the risk of cardiovascular disease, through down-regulation of monocyte activation in the blood. Monocytes are the major circulating blood cells involved in the progression of cardiovascular disease. High cut-off hemodialysis in chronic dialysis patients results in a sustained decrease in expression of monocyte cell- surface proteins that direct the movement of these cells from the blood to the walls of blood vessels, where they promote the progression of arterial disease (atherosclero- sis) that leads to cardiovascular disease (CVD); heart dis- ease, strokes and peripheral vascular disease.
Cockwell Paul
Gohl Hermann
Hutchison Colin
Krause Bernd
Storr Markus
Gambro Lundia Ab
Gowling Lafleur Henderson Llp
University Hospitals Birmingham Nhs Foundation Trust
LandOfFree
High cut-off hemodialysis membranes for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with High cut-off hemodialysis membranes for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High cut-off hemodialysis membranes for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1751670